In critical care, we’ve been treating patients with opioid use disorder for a long time. If they’re intubated for intoxication, we extubate them and send them home. If they’re septic with endocarditis, we treat their sepsis. Unfortunately, this isn’t enough. We’re treating the complications of opioid use disorder, without addressing the underlying problem.
Recently, medication-assisted therapy with buprenorphine has emerged as a powerful approach to treat opioid use disorder itself. Maximally aggressive care for these patients may require both treating their acute problem (e.g., respiratory failure, sepsis) and also treating their underlying opioid use disorder.
The IBCC chapter is located here.
- The podcast & comments are below.
The podcast will be coming eventually.
Follow us on iTunes
- IBCC chapter – Disseminated Intravascular Coagulation (DIC) - January 18, 2021
- PulmCrit- RCTs don't justify using convalescent plasma or antibody cocktails - January 14, 2021
- PulmCrit – Six RCTs to answer one question: what is the role of tocilizumab in COVID-19? - January 12, 2021